Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics

Usman Adam, Nusrat Husain, Peter M Haddad, Tariq Munshi, Fauzia Tariq, Farooq Naeem, Imran B ChaudhryBackground: Tardive dyskinesia (TD) is a side effect of antipsychotic treatment that often only appears after months or years of treatment. A systematic review of randomized controlled trials lastin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Adam UU, Husain N, Haddad PM, Munshi T, Tariq F, Naeem F, Chaudhry IB
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/46735a3513ae4310b590bface71137c9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:46735a3513ae4310b590bface71137c9
record_format dspace
spelling oai:doaj.org-article:46735a3513ae4310b590bface71137c92021-12-02T00:35:28ZTardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics1178-2021https://doaj.org/article/46735a3513ae4310b590bface71137c92014-10-01T00:00:00Zhttp://www.dovepress.com/tardive-dyskinesia-in-a-south-asian-population-with-first-episode-psyc-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021 Usman Adam, Nusrat Husain, Peter M Haddad, Tariq Munshi, Fauzia Tariq, Farooq Naeem, Imran B ChaudhryBackground: Tardive dyskinesia (TD) is a side effect of antipsychotic treatment that often only appears after months or years of treatment. A systematic review of randomized controlled trials lasting more than 1 year showed that second-generation antipsychotics (SGAs) were associated with an approximately fivefold lower risk of TD compared to haloperidol in patients with chronic schizophrenia. In contrast, there is little research on the risk of TD with other first-generation antipsychotics (FGAs), and this applies especially to their use in the treatment of patients with first episode psychosis (FEP).Objectives: To determine the severity and point prevalence of TD in a naturalistic sample of patients with FEP in Pakistan treated with FGAs or SGAs.Methods: This was an observational study. TD was assessed by trained clinicians using the Abnormal Involuntary Movement Scale.Results: In the total sample (number =86) the mean age of patients was 26 years and the prevalence of TD (Schooler Kane criteria) was 29% with no significant difference between those treated with FGAs and SGAs (31% FGAs versus 26% SGAs; P=0.805). The Abnormal Involuntary Movement Scale total score (items 1–7), a measure of the severity of TD, was significantly higher for patients treated with FGAs versus those treated with SGAs (P=0.033). Scores on specific items showed that this reflected higher scores for dyskinesia affecting the muscles of facial expression, as well as of the upper and lower limb, whereas scores did not differ significantly in other body areas. Conclusion: FGAs were associated with greater severity, though not prevalence, of TD than SGAs. The study highlights the relatively high rate of TD in Asian FEP patients and the need for clinicians to monitor for this and other potential antipsychotic side effects during treatment. Keywords: first-generation antipsychotic, second-generation antipsychotic, Abnormal Involuntary Movement ScaleAdam UUHusain NHaddad PMMunshi TTariq FNaeem FChaudhry IBDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2014, Iss default, Pp 1953-1959 (2014)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Adam UU
Husain N
Haddad PM
Munshi T
Tariq F
Naeem F
Chaudhry IB
Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
description Usman Adam, Nusrat Husain, Peter M Haddad, Tariq Munshi, Fauzia Tariq, Farooq Naeem, Imran B ChaudhryBackground: Tardive dyskinesia (TD) is a side effect of antipsychotic treatment that often only appears after months or years of treatment. A systematic review of randomized controlled trials lasting more than 1 year showed that second-generation antipsychotics (SGAs) were associated with an approximately fivefold lower risk of TD compared to haloperidol in patients with chronic schizophrenia. In contrast, there is little research on the risk of TD with other first-generation antipsychotics (FGAs), and this applies especially to their use in the treatment of patients with first episode psychosis (FEP).Objectives: To determine the severity and point prevalence of TD in a naturalistic sample of patients with FEP in Pakistan treated with FGAs or SGAs.Methods: This was an observational study. TD was assessed by trained clinicians using the Abnormal Involuntary Movement Scale.Results: In the total sample (number =86) the mean age of patients was 26 years and the prevalence of TD (Schooler Kane criteria) was 29% with no significant difference between those treated with FGAs and SGAs (31% FGAs versus 26% SGAs; P=0.805). The Abnormal Involuntary Movement Scale total score (items 1–7), a measure of the severity of TD, was significantly higher for patients treated with FGAs versus those treated with SGAs (P=0.033). Scores on specific items showed that this reflected higher scores for dyskinesia affecting the muscles of facial expression, as well as of the upper and lower limb, whereas scores did not differ significantly in other body areas. Conclusion: FGAs were associated with greater severity, though not prevalence, of TD than SGAs. The study highlights the relatively high rate of TD in Asian FEP patients and the need for clinicians to monitor for this and other potential antipsychotic side effects during treatment. Keywords: first-generation antipsychotic, second-generation antipsychotic, Abnormal Involuntary Movement Scale
format article
author Adam UU
Husain N
Haddad PM
Munshi T
Tariq F
Naeem F
Chaudhry IB
author_facet Adam UU
Husain N
Haddad PM
Munshi T
Tariq F
Naeem F
Chaudhry IB
author_sort Adam UU
title Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
title_short Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
title_full Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
title_fullStr Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
title_full_unstemmed Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
title_sort tardive dyskinesia in a south asian population with first episode psychosis treated with antipsychotics
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/46735a3513ae4310b590bface71137c9
work_keys_str_mv AT adamuu tardivedyskinesiainasouthasianpopulationwithfirstepisodepsychosistreatedwithnbspantipsychotics
AT husainn tardivedyskinesiainasouthasianpopulationwithfirstepisodepsychosistreatedwithnbspantipsychotics
AT haddadpm tardivedyskinesiainasouthasianpopulationwithfirstepisodepsychosistreatedwithnbspantipsychotics
AT munshit tardivedyskinesiainasouthasianpopulationwithfirstepisodepsychosistreatedwithnbspantipsychotics
AT tariqf tardivedyskinesiainasouthasianpopulationwithfirstepisodepsychosistreatedwithnbspantipsychotics
AT naeemf tardivedyskinesiainasouthasianpopulationwithfirstepisodepsychosistreatedwithnbspantipsychotics
AT chaudhryib tardivedyskinesiainasouthasianpopulationwithfirstepisodepsychosistreatedwithnbspantipsychotics
_version_ 1718403612470673408